Melinta Therapeutics competitorsClear all

Melinta Therapeutics's top competitors include Cardiorentis, Genoa Pharmaceuticals, GBT (Global Blood Therapeutics) and CTI BioPharma.
Melinta Therapeutics
Melinta Therapeutics
Melinta Therapeutics is an antibiotics-focused company that develops and commercializes antibiotics to overcome drug-resistant infections.
Cardiorentis
Cardiorentis
Cardiorentis is a biopharmaceutical company, developing drug therapies for the treatment of acute heart failure and related cardiovascular diseases.
Genoa Pharmaceuticals
Genoa Pharmaceuticals
Genoa Pharmaceuticals develops therapies for the treatment of idiopathic pulmonary fibrosis.
GBT (Global Blood Therapeutics)
GBT (Global Blood Therapeutics)
GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
CTI BioPharma
CTI BioPharma
CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies covering a spectrum of blood-related cancers that offer a benefit to patients and healthcare providers.
Founding Date
Founding Date
2000
Founding Date
N/A
Founding Date
2011
Founding Date
2012
Founding Date
1992
Type
Type
Public
Type
Private
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
HQ
New Haven, US
Locations
Zug, CH HQ
Freienbach, CH
Locations
Seattle, US HQ
Locations
South San Francisco, US HQ
Locations
Seattle, US HQ
Employees
Employees
2612% decrease
Employees
N/A
Employees
2
Employees
17116% increase
Employees
4621% decrease
Valuation ($)
Valuation ($)
24.6 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
3.2 b
Valuation ($)
49.5 m
Twitter followers
Twitter followers
349
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
1.2 k
Twitter followers
183
Alexa Website Rank
Alexa Website Rank
339859
Alexa Website Rank
N/A
Alexa Website Rank
N/A
Alexa Website Rank
762666
Alexa Website Rank
796309

Financial

Net income
Net income
N/A
Net income
N/A
Net income
N/A
Net income
($174.2m) (FY, 2018)
Net income
($29.3m) (FY, 2018)

Funding

Total funding raised
Total funding raised
$ 519.2m
Total funding raised
$ 118.5m
Total funding raised
$ 64.2m
Total funding raised
$ 88.7m
Total funding raised
$ 105m
For sources of this data, please see the company profile

View company profiles

Cardiorentis
HQ
Zug, CH

Cardiorentis is a biopharmaceutical company, developing drug therapies for the treatment of acute heart failure and related cardiovascular diseases.

View company
Genoa Pharmaceuticals
HQ
Seattle, US
Employees
2

Genoa Pharmaceuticals develops therapies for the treatment of idiopathic pulmonary fibrosis.

View company
GBT (Global Blood Therapeutics)
HQ
South San Francisco, US
Employees
171↑ 16% increase

GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.

View company
CTI BioPharma
HQ
Seattle, US
Employees
46↓ 21% decrease

CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies covering a spectrum of blood-related cancers that offer a benefit to patients and healthcare providers.

View company